A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized ...

The first national conference on HPV in Indy discussed advances like self-collected HPV testing for cancer prevention.

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

The United States has seen progress in reducing certain cancer risks, as overall smoking rates remain on a decline. But for ...

The Nasarawa State Primary Health Care Development Agency has disclosed that no fewer than 810 health facilities across the ...

This study demonstrated that the inflammatory response in a subset of anal, penile, and vulvar HSILs was associated with ...

HPV is a leading cause of cervical cancer in women, but 50% of people who develop the cancer are never tested. A self-collection test could help.

PHASE Scientific (PHASE) proudly announced a major milestone this week with its inaugural participation and award-winning presentation at the 2025 American Society for Colposcopy and Cervical ...

India introduces its first affordable, indigenous HPV test kits, aiming to boost early detection and fight cervical cancer ...